e-Consultation with Medical oncologists

Professional statement

Dr Aspasia Soultati is an exceptionally skilled consultant medical oncologist in East Sussex. She is an expert in numerous types of cancer, including genitourinary cancers (kidney cancer, bladder cancer and prostate cancer), and is also highly specialised in lower GI (gastrointestinal) cancers, such as colorectal cancer. In fact, Dr Soultati's expertise has led her to become the oncology lead for the cancer unit at Eastbourne and Conquest NHS Foundation Trust.  Patients can access her private healthcare services at Nuffield Health Brighton Hospital, which also covers the areas of Eastbourne and Conquest. In both private and public care settings, she provides a variety of treatments, including chemotherapy, target therapy and immunotherapy. She also collaborates with Healthcare at Home to offer chemotherapy at home.   Dr Soultati underwent extensive specialist training in Athens, Greece, which is where she also earned her PhD. Following this, she relocated to the UK to continue her training at the well known Guy's and St Thomas' Hospital in London. Additionally, she pursued postdoctoral translational research in renal cancers with a team of world-renowned scientists at the Francis Crick Institute, also in London. She is an avid researcher and has made numerous contributions to cancer research. She makes every effort to transform the experience of patients with cancer across Sussex by providing professional and personalised care, and by encouraging research investigations to improve patient outcomes in oncology.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Sarah Khan is a consultant medical oncologist who is based in Nottinghamshire. She has a wide area of expertise which includes a special interest in all stages of lung cancer and breast cancer (female and male).  She is highly experienced in the treatment of all stages of breast cancer, as well as all stages of lung cancer. Her knowledge of lung cancer also includes lung neuroendocrine tumours, thymomas and mesotheliomas. Dr Khan provides several treatment options and is dedicated to providing the utmost high quality of professional, friendly and personalised care. She provides chemotherapy, immunotherapy, biological treatment, hormone therapies, targeted therapies and endocrine treatment. After qualifying from the University of Sheffield in 1996, Dr Khan underwent training in medical oncology at Nottingham University Hospital. This was followed by a clinical research fellowship and higher specialist training at the University of Nottingham to obtain her DM and MSc in oncology. By undergoing continuous professional development via training courses and meetings, she ensures that she is truly up-to-date with the latest knowledge and techniques. Not only does she dedicate her career to patient care, but also to medical research regarding cancer treatment. She is active in clinical research trials as well as the recruitment of patients for these trials. This includes advanced breast cancer, triple negative cancer, hormone positive cancer chemotherapy, immunotherapy and more. 

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Angela George is a consultant medical oncologist in gynaecology and practices at the Royal Marsden Hospital in Chelsea, London. She attends to both private and NHS referrals at her clinic, specialising in treatment of gynaecological cancers such as ovarian and endometrial with a particular focus on the use of genomic information in treatment. Her specialist knowledge surrounding genomic profiling and use of mutational information and inherited cancer syndromes assists Dr George in guiding her treatment at the Royal Marsden Hospital, where she is also clinical director of genomics. Furthermore, her oncogenetics practice takes in testing for inherited cancer syndromes. Dr George began her training in medical oncology in New Zealand, moved to the Royal Marsden Hospital and undertook additional training in oncogenetics at the Institute of Cancer in London. It was here where she was awarded the Chairman's Prize for her thesis in ovarian cancer genetics. Her genomics expertise saw her implement the Mainstreaming Cancer Genetics programme, which ran from 2013-2018. Her work has been adopted across the UK and across the world. The programme involved the introduction of genetic testing into the routine care of patients with ovarian, breast and pancreatic cancers and the current programmes have expanded into multiple tumour types. Further to her industry-leading work, Dr George is the Cancer Clinical Lead of the North London Genomic Medicine Service and co-chairs the molecular tumour board. She also is involved in the National Cancer Research Institute gynaecological cancers group, the Precision Medicine working group for the European Society of Medical Oncology and the British Society of Genetic Medicine (BSGM). Dr George is the principal investigator at The Royal Marsden for multiple international trials and her research, particularly in cancer genomics and targeted treatments, has featured widely in various books and peer-reviewed publications.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Dionysis Papadatos-Pastos is an exceptionally skilled and knowledgable consultant medical oncologist in London. He specialises in the treatment of lung cancer, mesothelioma, and thymoma. Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies and chemotherapy. He graduated in medicine at the University of Athens with distinction, which was followed by his PhD in Medical Oncology in 2012,  with First Class honours. He trained in medical oncology at The Royal Marsden, St George’s University Hospitals and Guy’s and St Thomas’. He was awarded a diploma in medical oncology at the Institute of Cancer Research at the University of London. Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has also presented  at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Shivan Sivakumar is a senior medical oncologist at Genesis Care and Churchill Hospital, in Oxford. His areas of expertise include pancreatic cancer, liver cancer and cholangiocarcinoma (bile duct cancer), as well as treatments such as chemotherapy and immunotherapy. He is extremely passionate about finding new solutions for stubborn diseases and has led numerous clinical trials and investigative studies. Throughout his career, Dr Sivakumar has developed a reputation for both the quality of his care and the speed with which he attends to patients. He tailors his care to the individual needs of his patients, offering home treatments such as chemotherapy.  He is an honorary consultant in medical oncology at Oxford University Hospitals NHS Foundation Trust and a clinical career development fellow in medical oncology at the University of Oxford. Additionally, he is a pancreatic cancer lead for Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre, an international partnership created with the purpose of sharing ideas, resources and research findings across two continents, in order to improve cancer treatment in both regions.  Dr Sivakumar has been educated to the highest standards, he achieved his Bachelor of Medicine, Bachelor of Surgery degree from Queen Mary University of London and went on to gain membership of the Royal College of Surgeons. In 2014 he was awarded a PhD by the University of Cambridge for his groundbreaking work in the field of biochemistry. He also completed post-doctoral studies in immunology and training in early phase clinical trials at the University of Oxford. Despite his impressive educational background, Dr Sivakumar continues to conduct research, the findings of which have been published in countless peer-reviewed journals. In 2020 he was awarded the "Future of Research" award by the National Cancer Research Institute.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Dr Mark Tuthill is an experienced consultant medical oncologist and an expert in the use of immunotherapy in cancer treatment. Practicing at the Manor Hospital and GenesisCare in Oxford, Dr Tuthill specialises in the treatment of early and recurrent cancer including breast cancer, prostate cancer,kidney cancer, and bladder cancer  Treatment is personalised to each patient's needs and preferences and can include the use of chemotherapy, hormone therapy, immunotherapy, or cancer growth inhibitors. Dr Tuthill originally qualified from University College London, and trained in Medical Oncology in London at the Royal Marsden, Hammersmith, Charing Cross, and the Chelsea and Westminster Hospitals. In 2015 he was appointed Consultant Medical Oncologist at Churchill Hospital, Oxford, where he acts as principal investigator on a number of clinical trials. Dr Tuthill’s research interests include tumour immunology, cancer-growth inhibitors, and novel therapeutic drug combinations for the treatment of cancer. He is a principal investigator or sub-investigator for early and late phase clinical trials in tumour types including breast cancer, urological cancers and other tumour types. Dr Tuthill holds a PhD in Tumour Immunology from Imperial College London and regularly presents his research at national and international conferences. He is a clinical ambassador for UCARE (Urology Cancer Research and Education), an independent charity raising funds for research into prostate and bladder cancer, and is a member of The Association of Cancer Physicians. Dr Tuthill has a medico-legal practice supported by a dedicated a highly professional medico-legal administrative team and medico-legal analysts. He writes clear concise reports to time and client satisfaction.

*Translated with Google translator. We apologize for any imperfection

Professional statement

Professor Robert Leonard is a renowned consultant medical oncologist in London with a major interest in the management of breast cancer. His areas of expertise include gynaecological cancer, sarcoma, lymphomas, colon cancer and fertility cancer therapy. Professor Leonard is the Professor of cancer studies at Imperial College and the Lead Clinician of cancer services at Imperial College Healthcare NHS Trust, as well as the Chief of Service for medical oncology. Professor Leonard was awarded the Cancer Research Campaign Travelling Fellowship in 1981 to train as a Clinical Fellow at the Dana Farber Cancer Institute in Boston. He returned to the UK to take up a senior lectureship and consultant post in Edinburgh, where he worked for 19 years to start the academic medical oncology department. He was chair of medical oncology and chair of the South West Wales Cancer Institute in 2001 and left after five years to lead the oncology department at Imperial College NHS trust as Professor of Oncology. Professor Leonard is the ex-Chair of the Scientific Board for Breast Cancer Care UK and remains a senior advisor to Cancer Research UK. He has published over 350 papers on the biology and treatment of human cancer for over 40 years. He retired from the NHS in 2011 but still practices privately in some of London’s key hospitals and clinics.

*Translated with Google translator. We apologize for any imperfection